Finally, the development of CAR-T cells engineered to secrete proinflammatory cytokines (such as IL-12, IL-15 and IL-18), to produce molecules engaging tumor cells by not engineered T cells (162–166), as well as the development of strategies to overcome cell exhaustion could also be required (140, 167, 168). The gene discussed is IL18; the disease is neoplasm.